These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23050389)

  • 41. Compounding pharmacy: old methods finding a new niche.
    Matheny C; Martin CM
    Consult Pharm; 2010 Jun; 25(6):357-63. PubMed ID: 20534406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy.
    Rhoads R
    Int J Pharm Compd; 2018; 22(2):129-134. PubMed ID: 29877860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871.
    Rice B
    Int J Pharm Compd; 2017; 21(4):290-291. PubMed ID: 28719371
    [No Abstract]   [Full Text] [Related]  

  • 44. APhA house of delegates endorses policies on pharmaceutical care, therapeutic outcomes, compounding, packaging.
    Am J Hosp Pharm; 1992 Jun; 49(6):1318. PubMed ID: 1529970
    [No Abstract]   [Full Text] [Related]  

  • 45. Implementing United States pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, part 2: documentation and verification.
    Allen LV
    Int J Pharm Compd; 2012; 16(3):230-4. PubMed ID: 23050301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Society of Hospital Pharmacists of Australia: are you at risk?
    Aust Hosp; 1981 Jul; (54):4-5. PubMed ID: 10254354
    [No Abstract]   [Full Text] [Related]  

  • 47. Development of a standardized Intranet database of formulation records for nonsterile compounding, Part 2.
    Haile M; Anderson K; Evans A; Crawford A
    Int J Pharm Compd; 2012; 16(2):104-9. PubMed ID: 23050321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The International Academy of Compounding Pharmacists Introduces a New President.
    Rice B
    Int J Pharm Compd; 2017; 21(2):116-117. PubMed ID: 28346206
    [No Abstract]   [Full Text] [Related]  

  • 49. Unsubstantiated maligning of pharmacists who compound.
    Padron VA
    Am J Health Syst Pharm; 1996 May; 53(9):1080. PubMed ID: 8744473
    [No Abstract]   [Full Text] [Related]  

  • 50. [Medicines raw materials used in compounding medicines: an update of the legislation].
    Huyghebaert C; Leuckx S
    J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391
    [No Abstract]   [Full Text] [Related]  

  • 51. Compounding problems and compounding confusion: federal regulation of compounded drug products and the FDAMA circuit split.
    Boodoo JM
    Am J Law Med; 2010; 36(1):220-47. PubMed ID: 20481406
    [No Abstract]   [Full Text] [Related]  

  • 52. The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: AN UNSPOKEN OPPORTUNITY FOR PHARMACISTS.
    Parks KC; Bernard B; Cogdill CB
    Int J Pharm Compd; 2015; 19(5):377-80. PubMed ID: 26775444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sources of regulatory information for pharmacists.
    Goldwire MA; Rumore MM
    Am J Hosp Pharm; 1993 Jun; 50(6):1175-81. PubMed ID: 8517457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Compounding: if not pharmacists, then who?
    Laven DL
    Am Pharm; 1991 Apr; NS31(4):7. PubMed ID: 2038965
    [No Abstract]   [Full Text] [Related]  

  • 57. Influenza vaccine formulation and effectiveness.
    Ribaudo AS; Hayney MS
    J Am Pharm Assoc (2003); 2017; 57(5):637-639. PubMed ID: 28882251
    [No Abstract]   [Full Text] [Related]  

  • 58. Patient Access Is a Patient Safety Issue.
    Pore D
    Int J Pharm Compd; 2019; 23(2):120-121. PubMed ID: 31085777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compounded medicines and 'off label' prescribing - a case for more guidance.
    Fois RA; Mewes BT; McLachlan AJ; Ramzan I
    Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Misinterpretations of United States pharmacopeia chapter <797>.
    McElhiney LF
    Int J Pharm Compd; 2012; 16(1):6-10. PubMed ID: 23050305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.